| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
School of Pharmacy, University of Colorado, Boulder, Colorado 80309
The regulatory molecule, cyclic adenosine 3':5'-monophosphate (cAMP), can inhibit cell proliferation, reverse the neoplastic phenotype, and promote tumor regression. Since the biological effects of cAMP are mediated by an activation of protein kinase enzymes, the interaction of cAMP with the regulatory subunits of type I and II isozymes (RI and RII) was studied in normal and neoplastic tissues. Regulatory subunits in extracts from normal adult and neonatal lung, urethan-induced lung adenoma, and uninvolved lung tissue were covalently labeled with 8-azidoadenosine cyclic 3':5'-[32P]monophosphate (8-N3-[32P]cAMP), a specific photoaffinity analog of cAMP. The ability of RI to bind 8-N3-[32P]cAMP is the same in all tissues, while RII binding characteristics depend on both developmental stage and neoplastic state. Binding curves for RII from normal adult lung suggest two 8-N3-[32P]cAMP binding sites, one which saturates at 125 nM and one which saturates at 800 nM. The RII from tumor tissue appears to have only the low-affinity site, while RII from neonatal lung shows greatly reduced binding to both sites. These changes in 8-N3-[32P]-cAMP binding characteristics correlated with changes in the cAMP dependence of RII autophosphorylation. In adult lung, cAMP can either stimulate or inhibit endogenous phosphorylation of RII, depending on the divalent cation (Mg2+ or Zn2+, respectively) present during the reaction. In the tumor, cAMP has little stimulatory effect but is strongly inhibitory. The amount of 32P that can be incorporated into neonatal RII is very slight with either cation. Thus, both the 8-N3-[32P]cAMP binding sites on RII and the phosphorylatable sites on RII change during normal and neoplastic development. Tumor growth is unregulated by normal physiological constraints. A decreased responsiveness to alterations in intracellular cAMP concentrations in lung adenomas may increase the proliferative rate and help maintain the neoplastic state.
1 Supported by USPHS Grants ES02370 and RR 09065 and by the Colorado Heart Association.
2 To whom requests for reprints should be addressed.
Received 9/29/80. Accepted 12/16/80.
This article has been cited by other articles:
![]() |
L. M. Salvador, M. P. Flynn, J. Avila, S. Reierstad, E. T. Maizels, H. Alam, Y. Park, J. D. Scott, D. W. Carr, and M. Hunzicker-Dunn Neuronal Microtubule-associated Protein 2D Is a Dual A-kinase Anchoring Protein Expressed in Rat Ovarian Granulosa Cells J. Biol. Chem., June 25, 2004; 279(26): 27621 - 27632. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Porter, L. D. Dwyer-Nield, and A. M. Malkinson Regulation of lung epithelial cell morphology by cAMP-dependent protein kinase type I isozyme Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1282 - L1289. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |